Phase I–II Trial of Prolonged Gemcitabine Infusion Plus Paclitaxel as a Biweekly Schedule for Advanced Breast Cancer Patients Pretreated With Anthracyclines

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-010-1369-y